H. Akama

发表

Safety, tolerability and pharmacokinetics of a novel phosphodiesterase inhibitor, E6005 ointment, in healthy volunteers and in patients with atopic dermatitis

F. Ohba, Maiko Nomoto, S. Hojo, 2016, The Journal of dermatological treatment.

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial

H. Nakagawa, M. Furue, Nobukazu Hayashi, 2014, The Journal of dermatology.

Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study

S. Imayama, K. Matsuguma, F. Ohba, 2016, The Journal of dermatological treatment.

Raised plasma adrenomedullin in patients with systemic sclerosis complicated by pulmonary hypertension

N. Kamatani, H. Akama, M. Hara, 2000, Annals of the rheumatic diseases.

Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease.

A. Taniguchi, T. Furuya, H. Akama, 1996, Arthritis and rheumatism.

Glucocorticoid receptor and inhibition of 3-O-methyl-D-glucose uptake by glucocorticoids in peripheral blood leukocytes from normal humans: correlation between receptor level and hormone effect in vitro.

Y. Ichikawa, I. Makino, M. Homma, 1992, Acta endocrinologica.

Glucocorticoid Receptors in NormalLeukocytes: Effectsof Age,Gender,Season, andPlasmaCortisol Concentrations

Y. Ichikawa, Hirotoshi Tanaka, M. Homma, 1991 .

Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus.

T. Mimori, M. Akizuki, Y. Takeda, 1987, The Journal of rheumatology. Supplement.

One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine

H. Yamanaka, N. Kamatani, C. Terai, 2006, Modern rheumatology.

Autoantibodies in pet dogs of patients with systemic lupus erythematosus

Hirotoshi Tanaka, H. Akama, 1992, The Lancet.

Pancytopenia and Colitis with Clostridium difficile in a Rheumatoid Arthritis Patient Taking Methotrexate, Antibiotics and Non-steroidal Anti-inflammatory Drugs

N. Kamatani, H. Akama, S. Kotake, 2001, Clinical Rheumatology.

Mononuclear cells enhance prostaglandin E2 production of polymorphonuclear leukocytes via tumor necrosis factor alpha.

Y. Ichikawa, M. Homma, H. Akama, 1990, Biochemical and biophysical research communications.

Methotrexate in the treatment of rheumatoid arthritis.

Y. Ichikawa, Hirotoshi Tanaka, Hidehiro Yamada, 1989 .

Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy.

Y. Ichikawa, I. Makino, M. Homma, 1992, The Journal of rheumatology.

In vivo responsiveness to glucocorticoid correlated with glucocorticoid receptor content in peripheral blood leukocytes in normal humans.

Y. Ichikawa, M. Homma, H. Akama, 1989, Acta endocrinologica.

Rapidly progressive glomerulonephritis with D-penicillamine.

N. Kamatani, C. Terai, H. Akama, 2000, The American journal of the medical sciences.

Progressive appearance of overlap syndrome together with autoantibodies in a patient with fatal thrombotic microangiopathy.

N. Kamatani, H. Akama, H. Yamanaka, 2000, The American journal of the medical sciences.

Pulmonary pseudolymphoma presented with a mass lesion in a patient with primary Sjögren's syndrome: beneficial effect of intermittent intravenous cyclophosphamide.

M. Akizuki, M. Homma, H. Akama, 1993, Scandinavian journal of rheumatology.

[Pharmacogenetics of disease modifying anti-rheumatic drugs].

A. Taniguchi, H. Yamanaka, N. Kamatani, 2002, Nihon rinsho. Japanese journal of clinical medicine.

Alkaline Phosphatase in Rheumatoid Arthritis Patients: Possible Contribution of Bone-Type ALP to the Raised Activities of ALP in Rheumatoid Arthritis Patients

N. Kamatani, H. Akama, S. Kotake, 2002, Clinical Rheumatology.

A new syndrome: multiple dislocations of distal interphalangeal joints associated with interstitial pneumonia, Sjögren's syndrome, and positive autoantibodies

N. Kamatani, H. Akama, S. Kotake, 2003, Modern rheumatology.

Multiple dislocations of distal interphalangeal joints associated with interstitial pneumonia and Sjögren's syndrome: a possible new complex.

N. Kamatani, H. Akama, S. Kotake, 2000, The Journal of rheumatology.

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses.

A. Taniguchi, H. Yamanaka, N. Kamatani, 2002, Pharmacogenetics.

[Topics of glucocorticoids--centered on therapy for rheumatoid arthritis].

H. Akama, 2011, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Glucocorticoid-unresponsive fever in a patient with Weber-Christian disease.

H. Kameda, H. Akama, T. Yoshida, 1994, The British journal of clinical practice.

Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial

H. Yamanaka, N. Miyasaka, Yoshiya Tanaka, 2014, Rheumatology.

Homologous down-regulation of the glucocorticoid receptor down-modulates cellular hormone responsiveness in human histiocytic lymphoma U937 cells.

Y. Makino, H. Tanaka, I. Makino, 1994, Endocrine journal.

Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study

H. Yamanaka, N. Miyasaka, Yoshiya Tanaka, 2013, Annals of the rheumatic diseases.

[Lupus cystitis and peritonitis successfully treated with intravenous cyclophosphamide pulse therapy: a case report].

M. Harigai, A. Nakajima, H. Akama, 1998, Ryumachi. [Rheumatism].

Glucosamine and chondroitin for osteoarthritis.

H. Akama, S. Saito, 2001, Arthritis and rheumatism.

GS and CS might be useful in the treatment of patients with OA in hip, elbow, ankle, or finger joints.

I. Leden, H. Akama, Saito S. Glucosamine, 2001 .

Acute sympathetic hyperfunction in overlapping syndromes of systemic lupus erythematosus and polymyositis.

C. Terai, A. Nakajima, H. Akama, 1998, The Journal of rheumatology.

[MPO-ANCA positive rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with D-penicillamine].

N. Kamatani, C. Terai, H. Akama, 1999, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Antiphospholipid syndrome with complete abdominal aorta occlusion and chondritis

N. Kamatani, M. Harigai, C. Terai, 2001, Modern rheumatology.

Progressive renal failure in patients with lupus nephritis

Y. Ichikawa, H. Akama, H. Oshima, 1993, Journal of internal medicine.

Involvement of tumor necrosis factor alpha in experimentally induced hepatitis.

H. Akama, 1991, Gastroenterology.

Involvement of tumor necrosis factor α in experimentally induced hepatitis

H. Akama, 1991 .

Glucocorticoid receptors in normal leukocytes: effects of age, gender, season, and plasma cortisol concentrations.

Y. Ichikawa, M. Homma, H. Akama, 1991, Clinical chemistry.

Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis

H. Akama, 1990, The Lancet.

[Pharmacogenomics of the immunosuppressive agents].

A. Taniguchi, N. Kamatani, E. Tanaka, 2002, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.